Your browser doesn't support javascript.
loading
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Watanabe, Hiromi; Ichihara, Eiki; Kayatani, Hiroe; Makimoto, Go; Ninomiya, Kiichiro; Nishii, Kazuya; Higo, Hisao; Ando, Chihiro; Okawa, Sachi; Nakasuka, Takamasa; Kano, Hirohisa; Hara, Naofumi; Hirabae, Atsuko; Kato, Yuka; Ninomiya, Takashi; Kubo, Toshio; Rai, Kammei; Ohashi, Kadoaki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki.
Afiliação
  • Watanabe H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Ichihara E; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Kayatani H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Makimoto G; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Ninomiya K; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Nishii K; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Higo H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Ando C; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Okawa S; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Nakasuka T; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kano H; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Hara N; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Hirabae A; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kato Y; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Ninomiya T; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kubo T; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Rai K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Ohashi K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Tabata M; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Maeda Y; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Cancer Sci ; 112(5): 1853-1864, 2021 May.
Article em En | MEDLINE | ID: mdl-33410241
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores da Angiogênese / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Neoplasias Pulmonares / Neovascularização Patológica Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Inibidores da Angiogênese / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Neoplasias Pulmonares / Neovascularização Patológica Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Cancer Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão